BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21349849)

  • 21. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
    Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP
    Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS.
    Goodall EF; Greenway MJ; van Marion I; Carroll CB; Hardiman O; Morrison KE
    Neurology; 2005 Sep; 65(6):934-7. PubMed ID: 16186539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Q283P amino-acid change in HFE leads to structural and functional consequences similar to those described for the mutated 282Y HFE protein.
    Ka C; Le Gac G; Dupradeau FY; Rochette J; Férec C
    Hum Genet; 2005 Sep; 117(5):467-75. PubMed ID: 15965644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurons overexpressing mutant presenilin-1 are more sensitive to apoptosis induced by endoplasmic reticulum-Golgi stress.
    Terro F; Czech C; Esclaire F; Elyaman W; Yardin C; Baclet MC; Touchet N; Tremp G; Pradier L; Hugon J
    J Neurosci Res; 2002 Aug; 69(4):530-9. PubMed ID: 12210846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hepcidin gene promoter nc.-1010C > T; -582A > G haplotype modulates serum ferritin in individuals carrying the common H63D mutation in HFE gene.
    Silva B; Pita L; Gomes S; Gonçalves J; Faustino P
    Ann Hematol; 2014 Dec; 93(12):2063-6. PubMed ID: 25015054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis.
    van Rheenen W; Diekstra FP; van Doormaal PT; Seelen M; Kenna K; McLaughlin R; Shatunov A; Czell D; van Es MA; van Vught PW; van Damme P; Smith BN; Waibel S; Schelhaas HJ; van der Kooi AJ; de Visser M; Weber M; Robberecht W; Hardiman O; Shaw PJ; Shaw CE; Morrison KE; Al-Chalabi A; Andersen PM; Ludolph AC; Veldink JH; van den Berg LH
    Neurobiol Aging; 2013 May; 34(5):1517.e5-7. PubMed ID: 23063643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations of the HFE gene among Turkish hereditary hemochromatosis patients.
    Simsek H; Balaban YH; Yilmaz E; Sumer H; Buyukasik Y; Cengiz C; Ozcebe O; Hascelik G; Tatar G
    Ann Hematol; 2005 Oct; 84(10):646-9. PubMed ID: 15871018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The haemochromatosis protein HFE induces an apparent iron-deficient phenotype in H1299 cells that is not corrected by co-expression of beta 2-microglobulin.
    Wang J; Chen G; Pantopoulos K
    Biochem J; 2003 Mar; 370(Pt 3):891-9. PubMed ID: 12464008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in the HFE gene and sporadic amyotrophic lateral sclerosis risk: a meta-analysis of observational studies.
    Li M; Wang L; Wang W; Qi XL; Tang ZY
    Braz J Med Biol Res; 2014 Feb; 47(3):215-22. PubMed ID: 24604426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain.
    Aranda N; Viteri FE; Montserrat C; Arija V
    Ann Hematol; 2010 Aug; 89(8):767-73. PubMed ID: 20107990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HFE mutation H63D predicts risk of iron over load in thalassemia intermedia irrespective of blood transfusions.
    Sharma V; Panigrahi I; Dutta P; Tyagi S; Choudhry VP; Saxena R
    Indian J Pathol Microbiol; 2007 Jan; 50(1):82-5. PubMed ID: 17474269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective role of calreticulin in HFE hemochromatosis.
    Pinto JP; Ramos P; de Almeida SF; Oliveira S; Breda L; Michalak M; Porto G; Rivella S; de Sousa M
    Free Radic Biol Med; 2008 Jan; 44(1):99-108. PubMed ID: 18045552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HFE genotype and iron metabolism in Chinese patients with myelodysplastic syndromes and aplastic anemia.
    Nie L; Li L; Yang L; Zhang Y; Xiao Z
    Ann Hematol; 2010 Dec; 89(12):1249-53. PubMed ID: 20563578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on HFE gene mutations in patients with myelodysplastic syndromes and aplastic anemia].
    Nie L; Ai XF; Zheng YZ; Li QH; Yang L; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):223-8. PubMed ID: 19731820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HFE mutations and Alzheimer's disease.
    Connor JR; Lee SY
    J Alzheimers Dis; 2006 Nov; 10(2-3):267-76. PubMed ID: 17119292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the HFE gene (C282Y, H63D and S65C) mutations in a general Chinese Han population.
    Lin A; Yan WH; Xu HH; Zhu M; Zhou MY
    Tissue Antigens; 2007 Sep; 70(3):252-5. PubMed ID: 17661915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron homeostasis and H63D mutations in alcoholics with and without liver disease.
    Machado MV; Ravasco P; Martins A; Almeida MR; Camilo ME; Cortez-Pinto H
    World J Gastroenterol; 2009 Jan; 15(1):106-11. PubMed ID: 19115475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between the HFE mutations and unsuccessful ageing: a study in Alzheimer's disease patients from Northern Italy.
    Candore G; Licastro F; Chiappelli M; Franceschi C; Lio D; Rita Balistreri C; Piazza G; Colonna-Romano G; Grimaldi LM; Caruso C
    Mech Ageing Dev; 2003 Apr; 124(4):525-8. PubMed ID: 12714262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HFE H63D polymorphism is increased in patients with amyotrophic lateral sclerosis of Italian origin.
    Restagno G; Lombardo F; Ghiglione P; Calvo A; Cocco E; Sbaiz L; Mutani R; Chiò A
    J Neurol Neurosurg Psychiatry; 2007 Mar; 78(3):327. PubMed ID: 17308297
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of HFE variants on sphingolipid expression by SH-SY5Y human neuroblastoma cells.
    Ali-Rahmani F; Hengst JA; Connor JR; Schengrund CL
    Neurochem Res; 2011 Sep; 36(9):1687-96. PubMed ID: 21243428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.